While the FDA may consider an emergency use authorization, a coronavirus vaccine likely won’t be accessible to the general public until next year, says Healthcare Policy Analyst Chris Meekins.
Recorded June 24, 2020.
Economy & Policy March 20, 2023 CIO Larry Adam outlines the positive events that are outweighing...
Markets & Investing March 20, 2023 Doug Drabik discusses fixed income market conditions and offers...
Markets & Investing Recent market activity and rising interest rates have investors thinking twice about...